Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2358 to 2407 of 6456 in total 
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1179\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 9-4; keratin associated protein 9.4. [source:refseq;acc:nm\_033191]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.356\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.723\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.367\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1180\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial precursor (ec 1.3.5.1) (fp) (flavoprotein subunit of complex ii). [source:swissprot;acc:p31040]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
210.986\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.344\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.358\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase 21 kda proteolipid subunit (ec 3.6.3.14) (hatpl). [source:swissprot;acc:q99437]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.186\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.672\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02593\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1181\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
daz associated protein 1 isoform b; deleted in azoospermia associated protein 1. [source:refseq;acc:nm\_018959]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.268\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.916\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.352\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-sarcoglycan (gamma-sg) (35 kda dystrophin-associated glycoprotein) (35dag). [source:swissprot;acc:q13326]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.186\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.672\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02593\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1182\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neurocalcin delta. [source:swissprot;acc:p29554]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
225.104\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
230.931\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02589\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoic acid induced 17; pias-like protein hzimp10. [source:refseq;acc:nm\_020338]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.269\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.918\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.351\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1183\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-14; keratin associated protein 4.14. [source:refseq;acc:nm\_033059]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.346\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neuron specific calcium-binding protein hippocalcin (p23k) (calcium- binding protein bdr-2). [source:swissprot;acc:p32076]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.103\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
230.928\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02588\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1184\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
arf gtpase-activating protein git1 (g protein-coupled receptor kinase- interactor 1). [source:swissprot;acc:q9y2x7]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
216.729\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.334\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02586\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4.9 (fragment). [source:sptrembl;acc:q9byq8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5.346\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1185\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-12; keratin associated protein 4.12. [source:refseq;acc:nm\_031854]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
visinin-like protein 3 (vilip-3) (calcium-binding protein bdr-1) (hlp2) (hippocalcin-like protein 1). [source:swissprot;acc:p37235]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.094\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
230.913\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02585\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1186\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 7 (adp-ribosylation factor-like protein lak). [source:swissprot;acc:p56559]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
218.402\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.904\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02582\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 6 (stard6) (start domain- containing protein 6). [source:swissprot;acc:p59095]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5.346\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1187\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 5 (stard5) (start domain- containing protein 5). [source:swissprot;acc:q9nsy2]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase ac39 subunit) (v-atpase 40 kda accessory protein) (p39) (32 kda accessory protein). [source:swissprot;acc:p12953]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.402\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
212.904\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02582\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1188\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 4. [source:swissprot;acc:p40617]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-parvin (calponin-like integrin-linked kinase binding protein) (ch-ilkbp). [source:swissprot;acc:q9nvd7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.346\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1189\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-1-acid glycoprotein 2 precursor (agp 2) (orosomucoid 2) (omd 2). [source:swissprot;acc:p19652]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.649\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02565\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pinch protein (particularly interesting new cys-his protein) (lim and senescent cell antigen-like domains 1). [source:swissprot;acc:p48059]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5.346\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1190\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
integrin-linked protein kinase 1 (ec 2.7.1.-) (ilk-1) (59 kda serine/threonine protein kinase) (p59ilk). [source:swissprot;acc:q13418]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin. [source:swissprot;acc:p02248]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.372\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02558\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1191\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 4 (stard4) (start domain- containing protein 4). [source:swissprot;acc:q96dr4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.346\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
upstream binding protein 1 (lbp-1a). [source:refseq;acc:nm\_014517]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.742\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.237\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02558\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1192\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras suppressor protein 1 (rsu-1) (rsp-1). [source:swissprot;acc:q15404]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.346\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor cp2; transcription factor cp2, alpha globin. [source:refseq;acc:nm\_005653]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.742\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
215.237\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02558\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1193\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lbp-9. [source:refseq;acc:nm\_014553]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras-gtpase-activating protein binding protein 1 (gap sh3-domain binding protein 1) (g3bp-1). [source:swissprot;acc:q13283]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5.346\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1194\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-gtpase-activating protein binding protein 2 (gap sh3-domain binding protein 2) (g3bp-2). [source:swissprot;acc:q9un86]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor, arginine/serine-rich 3 (pre-mrna splicing factor srp20) (x16 protein). [source:swissprot;acc:p23152]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.742\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.237\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02558\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1195\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
espin. [source:refseq;acc:nm\_031475]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.346\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
skeletal muscle lim-protein 3 (slim 3) (lim-domain protein dral) (four and a half lim domains protein 2) (fhl-2). [source:swissprot;acc:q14192]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.608\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
276.493\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02554\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1196\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 2d6 (ec 1.14.14.1) (cypiid6) (p450-db1) (debrisoquine 4-hydroxylase). [source:swissprot;acc:p10635]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.346\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin protein. [source:refseq;acc:nm\_032559]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.858\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.264\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02551\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1197\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mstp028 protein. [source:refseq;acc:nm\_031954]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
219.042\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02548\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pleckstrin homology domain containing, family c (with ferm domain) member 1; mitogen inducible 2; kindlin 2. [source:refseq;acc:nm\_006832]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5.346\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1198\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim and senescent cell antigen-like domains 2; ilk-binding protein. [source:refseq;acc:nm\_017980]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
skeletal muscle lim-protein 2 (slim 2) (four and a half lim domains protein 3) (fhl-3). [source:swissprot;acc:q13643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
276.454\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02546\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1199\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
d(4) dopamine receptor (d(2c) dopamine receptor). [source:swissprot;acc:p21917]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.346\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u3 small nucleolar ribonucleoprotein protein mpp10 (m phase phosphoprotein 10). [source:swissprot;acc:o00566]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.496\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.508\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02543\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1200\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-10; keratin associated protein 4.10. [source:refseq;acc:nm\_033060]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.345\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
swi/snf related, matrix associated, actin dependent regulator of chromatin subfamily b member 1 (integrase interactor 1 protein) (hsnf5) (baf47). [source:swissprot;acc:q12824]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.604\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0254\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1201\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-2; keratin associated protein 4.2. [source:refseq;acc:nm\_033062]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.345\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial precursor (ec 1.3.5.1) (fp) (flavoprotein subunit of complex ii). [source:swissprot;acc:p31040]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.986\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.344\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0254\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1202\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
diphthamide biosynthesis-like protein 2. [source:refseq;acc:nm\_001384]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
227.274\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
233.041\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02537\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4.3 (fragment). [source:sptrembl;acc:q9byr4]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5.345\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1203\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 2-4; keratin associated protein 2.4. [source:refseq;acc:nm\_033184]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tumor necrosis factor, alpha-induced protein 1, endothelial (b12 protein). [source:swissprot;acc:q13829]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.023\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.606\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02536\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1204\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 1.5. [source:refseq;acc:nm\_031957]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.345\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/